Skip to main content
Livermore
Livermore
ZHEN

Front Row Advisors LLC

SEC CIK
0001729254
Latest filing
Aug 13, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
13
Since Q1 2021
Holdings of NBIX by Front Row Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−66−100.0%Sold outHolders
Q2 202466$9.09K<0.1%−10−13.2%ReducedHolders
Q1 202476$10.5K<0.1%+76NewHolders
Q4 20230$00.0%−65−100.0%Sold outHolders
Q3 202365$7.31K<0.1%−1−1.5%ReducedHolders
Q2 202366$6.00K<0.1%00.0%UnchangedHolders
Q1 202366$7.00K<0.1%−1−1.5%ReducedHolders
Q4 202267$8.00K<0.1%+6+9.8%AddedHolders
Q3 202261$7.00K<0.1%−16−20.8%ReducedHolders
Q2 202277$8.00K<0.1%+8+11.6%AddedHolders
Q1 202269$6.00K<0.1%+18+35.3%AddedHolders
Q4 202151$4.00K<0.1%00.0%UnchangedHolders
Q3 202151$5.00K<0.1%00.0%UnchangedHolders
Q2 202151$5.00K<0.1%00.0%UnchangedHolders
Q1 202151$5.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.